Nikhil Amin

9.1k total citations · 3 hit papers
80 papers, 1.9k citations indexed

About

Nikhil Amin is a scholar working on Physiology, Otorhinolaryngology and Immunology and Allergy. According to data from OpenAlex, Nikhil Amin has authored 80 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Physiology, 30 papers in Otorhinolaryngology and 29 papers in Immunology and Allergy. Recurrent topics in Nikhil Amin's work include Asthma and respiratory diseases (51 papers), Sinusitis and nasal conditions (30 papers) and Allergic Rhinitis and Sensitization (29 papers). Nikhil Amin is often cited by papers focused on Asthma and respiratory diseases (51 papers), Sinusitis and nasal conditions (30 papers) and Allergic Rhinitis and Sensitization (29 papers). Nikhil Amin collaborates with scholars based in United States, France and Germany. Nikhil Amin's co-authors include Leda Mannent, Joaquim Mullol, Tanya M. Laidlaw, Heribert Staudinger, Neil M.H. Graham, Katharine M. Woessner, Asif Khan, Gianluca Pirozzi, Paul Rowe and Marcella Ruddy and has published in prestigious journals such as Nature Medicine, American Journal of Respiratory and Critical Care Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

Nikhil Amin

75 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic Rhinosinusitis with Nasal Polyps and Asthma

2020 241 citations Tanya M. Laidlaw, Joaquim Mullol et al. The Journal of Allergy and Clinical Immunology In Practice profile →
Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials

2023 119 citations Gil Yosipovitch, Nicholas Mollanazar et al. Nature Medicine profile →
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials

2024 65 citations Marcus Maurer, Thomas B. Casale et al. Journal of Allergy and Clinical Immunology profile →

Peers

Countries citing papers authored by Nikhil Amin

Since Specialization

Citations

This map shows the geographic impact of Nikhil Amin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikhil Amin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikhil Amin more than expected).

Fields of papers citing papers by Nikhil Amin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikhil Amin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikhil Amin. The network helps show where Nikhil Amin may publish in the future.

Co-authorship network of co-authors of Nikhil Amin

This figure shows the co-authorship network connecting the top 25 collaborators of Nikhil Amin. A scholar is included among the top collaborators of Nikhil Amin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikhil Amin. Nikhil Amin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dupilumab Improves Lung Function, Asthma Control and Exacerbation Frequency in Allergic Bronchopulmonary Aspergillosis – Results from the Phase 2 LIBERTY ABPA AIRED Study 2025 ·American Journal of Respiratory and Critical Care Medicine ·Arnaud Bourdin, (unknown), Anand Shah, Caroline Baxter, (unknown), Nikhil Amin, (unknown), (unknown), Andrew P. Fontenot, Paula Dakin, Elizabeth Laws, Jennifer Maloney, (unknown), Allen Radin	2
2	Nurses’ perceptions of ethical climate, work environment, and quality of care in the UAE 2025 ·International Journal of Innovative Research and Scientific Studies ·Rana Obeidat, (unknown), (unknown), (unknown), Nikhil Amin, (unknown)	0
3	Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials breakdown → 2024 ·Journal of Allergy and Clinical Immunology ·Marcus Maurer, Thomas B. Casale, Sarbjit S. Saini, Moshe Ben‐Shoshan, Ana M. Giménez‐Arnau, Jonathan A. Bernstein, Akiko Yagami, (unknown), Allen Radin, Heribert Staudinger, Naimish Patel, Nikhil Amin, Bolanle Akinlade, Chunpeng Fan, Déborah Bauer, George D. Yancopoulos, Kiran Patel, Leda Mannent, Elizabeth Laws	65
4	Dupilumab significantly improves itch and hives in patients with chronic spontaneous urticaria (CUPID study C) 2024 ·Annals of Allergy Asthma & Immunology ·(unknown), Sarbjit S. Saini, Jonine L. Bernstein, Ana M. Giménez‐Arnau, Déborah Bauer, Nikhil Amin, (unknown), Paula Dakin, Elizabeth Laws, Allen Radin, Melanie Makhija	3
5	Preoperative very low-energy diets for obese patients undergoing intra-abdominal colorectal surgery: a retrospective cohort study (RetroPREPARE) 2024 ·Techniques in Coloproctology ·Tyler McKechnie, (unknown), (unknown), (unknown), (unknown), Kelly Brennan, (unknown), Nikhil Amin, (unknown), Sameer Parpia, Cagla Eskicioglu, Mohit Bhandari	2
6	Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma 2024 ·The Journal of Allergy and Clinical Immunology In Practice ·Ian Pavord, Klaus F. Rabe, Elliot Israel, Stanley J. Szefler, Guy Brusselle, (unknown), Arman Altincatal, Zhen Chen, Nikhil Amin, Asif Khan, David J. Lederer, Yi Zhang, Paul J. Rowe, Yamo Deniz, Amr Radwan, Juby A. Jacob‐Nara, William W. Busse	15
7	Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results 2023 ·Annals of Otology Rhinology & Laryngology ·Claus Bachert, Tanya M. Laidlaw, Seong Cho, Joaquim Mullol, Brian N. Swanson, Souâd Naimi, Marion Classe, Sivan Harel, Alexandre Jagerschmidt, Elizabeth Laws, Marcella Ruddy, Amy Praestgaard, Nikhil Amin, Leda Mannent	16
8	Efficacy of dupilumab in patients with uncontrolled, moderate‐to‐severe asthma with fungal sensitization 2023 ·Clinical & Experimental Allergy ·Jonathan Corren, Nicola A. Hanania, William W. Busse, Lawrence Sher, Arman Altincatal, Megan Hardin, Leda Mannent, Nikhil Amin, David J. Lederer, Xavier Soler, Juby A. Jacob‐Nara, Paul J. Rowe, Yamo Deniz	3
9	Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials breakdown → 2023 ·Nature Medicine ·Gil Yosipovitch, Nicholas Mollanazar, Sonja Ständer, Shawn G. Kwatra, Brian Kim, Elizabeth Laws, Leda Mannent, Nikhil Amin, Bolanle Akinlade, Heribert Staudinger, Naimish Patel, George D. Yancopoulos, David M. Weinreich, Sheldon Wang, Genming Shi, Ashish Bansal, John T. O’Malley	119
10	Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies 2022 ·Allergy ·Stella E. Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda Mannent, Yongtao Li, Shahid Siddiqui, Chien‐Chia Chuang, Siddhesh Kamat, Asif Khan	40
11	Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma 2021 ·Annals of Allergy Asthma & Immunology ·Tanya M. Laidlaw, Claus Bachert, Nikhil Amin, Martin Desrosiers, Peter W. Hellings, Joaquim Mullol, Jorge Máspero, Philippe Gevaert, Mei Zhang, (unknown), Asif Khan, Siddhesh Kamat, Naimish Patel, Neil M.H. Graham, Marcella Ruddy, Heribert Staudinger, Leda Mannent	75
12	Data Mining of Free-Text Responses: An Innovative Approach to Analyzing Patient Perspectives on Treatment for Chronic Rhinosinusitis with Nasal Polyps in a Phase IIa Proof-of-Concept Study for Dupilumab 2021 ·Patient Preference and Adherence ·Asif Khan, Adeline Abbé, Bruno Falissard, Paulo Carita, Claus Bachert, Joaquim Mullol, Matthew Reaney, Jingdong Chao, Leda Mannent, Nikhil Amin, Puneet Mahajan, Gianluca Pirozzi, Laurent Eckert	6
13	Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma 2020 ·ERJ Open Research ·Mario Castro, Klaus F. Rabe, Jonathan Corren, Ian Pavord, Constance H. Katelaris, Yuji Tohda, Bingzhi Zhang, Megan S. Rice, Jaman Maroni, Paul Rowe, Gianluca Pirozzi, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Neil M.H. Graham, Ariel Teper	38
14	Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis 2019 ·Allergy ·Claus Bachert, Peter W. Hellings, Joaquim Mullol, Daniel L. Hamilos, Philippe Gevaert, Robert M. Naclerio, Vijay N. Joish, Jingdong Chao, Leda Mannent, Nikhil Amin, Adeline Abbé, (unknown), Chunpeng Fan, Gianluca Pirozzi, Neil M.H. Graham, Puneet Mahajan, Heribert Staudinger, Asif Khan	74
15	Dupilumab reduces need for systemic corticosteroid use, sinonasal surgery in patients with severe chronic rhinosinusitis with nasal polyps : pooled results from the SINUS- 24, SINUS- 52 phase 3 studies 2019 ·Allergy ·Martin Desrosiers, Claus Bachert, Peter W. Hellings, C Hopkins, Heidi Olze, (unknown), Se Lee, (unknown), Xiang Lu, Nikhil Amin, Naimish Patel, (unknown), M. Ruddy, Heribert Staudinger, (unknown)	4
16	S49 Dupilumab improves lung function across baseline disease characteristics in patients with evidence of type 2 inflammation at baseline: the LIBERTY ASTHMA QUEST study 2019 ·Pierluigi Paggiaro, Mario Castro, (unknown), John Aubrey Douglass, Yuji Tohda, (unknown), (unknown), Paul Rowe, Nikhil Amin, Ariel Teper	1
17	Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma 2018 ·Annals of Allergy Asthma & Immunology ·Jonathan Corren, Mario Castro, Pascal Chanez, Leonardo M. Fabbri, Vijay N. Joish, Nikhil Amin, Neil M.H. Graham, Vera Mastey, Adeline Abbé, (unknown), Puneet Mahajan, Ariel Teper, Gianluca Pirozzi, Laurent Eckert	48
18	Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma 2018 ·Journal of Allergy and Clinical Immunology ·Steven F. Weinstein, Rohit Katial, Shyamalie Jayawardena, Gianluca Pirozzi, Heribert Staudinger, Laurent Eckert, Vijay N. Joish, Nikhil Amin, Jaman Maroni, Paul Rowe, Neil M.H. Graham, Ariel Teper	98
19	Dupilumab improves asthma-related patient reported outcomes in asthma patients with chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST 2018 ·Ghent University Academic Bibliography (Ghent University) ·Jonathan Corren, Mario Castro, Jorge Máspero, (unknown), Piotr Kuna, (unknown), Qunming Dong, (unknown), Heribert Staudinger, Jingdong Chao, Nikhil Amin, Gianluca Pirozzi, Marcella Ruddy, Bolanle Akinlade, Neil M.H. Graham, Ariel Teper, Asif Khan	10
20	Role of hepatobiliary scintigraphy in the evaluation and management of post-cholecystectomy pain due to biliary dyskinesia. 2002 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), Nikhil Amin	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact